Manchester Unity Credit Union Dec 11

  • ID: 2034572
  • December 2011
  • Standard & Poors
1 of 3

Very strong risk-adjusted capital ratio, offset by limited financial flexibility and very small absolute capital Good credit-loss history Good track record of support from small member base Gradually diminishing business base Very small capital base, limiting MUCU's ability to absorb unexpected losses Key-person risk and limited governance capability Our ratings on MUCU reflect the anchor stand-alone credit profile (SACP) for a financial institution operating only in New Zealand, plus MUCU's "very weak" business position, "very strong" capital and earnings, "weak" risk position, "below average" funding and "adequate" liquidity. Our bank criteria use the BICRA economic risk and industry risk scores to determine a bank's anchor SACP, the starting point in assigning an ICR. The anchor SACP for a bank operating...

Companies mentioned in this report are: Manchester Unity Credit Union
Action: Various Rating Actions

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Manchester Unity Credit Union

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.